Abstract

A simple, precise and accurate high performance thin layer chromatographic method has been developed for the simultaneous estimation of Isotretinoin and Erythromycin in pharmaceutical gel. The separation was carried out on Merck TLC aluminum sheets of silica gel 60 F254, (20 × 10 cm) with 250 µm thickness using toluene: DMSO: methanol (6.5:0.2:2.5, v/v/v) as a mobile phase. HPTLC separation of the two drugs followed by densitometric measurement of their spots at 340 nm for Isotretinoin before derivatization and 410 nm for Erythromycin after derivatization with 10% H2SO4 and heating at 100°C for 15 min. The drugs were satisfactorily resolved with RF values of 0.38 ± 0.02 and 0.55 ± 0.02 for Isotretinoin and Erythromycin, respectively. The accuracy and reliability of the method was assessed by evaluation of linearity (30-150 ng spot-1 for Isotretinoin and 1200-6000 ng spot-1 for Erythromycin), precision (intra-day RSD 0.62-0.79% and inter-day RSD 0.43-0.71 % for Isotretinoin and intra-day RSD 0.47-1.71 % and inter-day RSD 0.42-1.49 % for Erythromycin), accuracy (98.91 ± 0.92 % for Isotretinoin and 99.27 ± 0.72 % for Erythromycin), and specificity, in accordance with ICH guidelines.

Highlights

  • Isotretinoin (Figure 1(a)) is chemically (13cis)-retinoic acid

  • A comprehensive literature survey revealed that no method has been reported for simultaneous estimation of Isotretinoin and Erythromycin by HPTLC in pharmaceutical dosage forms

  • The present study is designed for the development and validation of simple HPTLC method for the simultaneous estimation of Isotretinoin and Erythromycin in their combined topical gel formulation

Read more

Summary

Introduction

Isotretinoin is a member of the large group of Vitamin A related compounds It alters DNA transcription and decreases the size and sebum output of the sebaceous glands. Literature review reveals that several analytical methods have been reported for Isotretinoin [10,11,12] and Erythromycin [13,14,15,16,17,18] as individual determination or in biological fluids or in combination with other drugs in pharmaceutical dosage forms. A comprehensive literature survey revealed that no method has been reported for simultaneous estimation of Isotretinoin and Erythromycin by HPTLC in pharmaceutical dosage forms. The present study is designed for the development and validation of simple HPTLC method for the simultaneous estimation of Isotretinoin and Erythromycin in their combined topical gel formulation. The proposed method is validated as per ICH guideline [19]

Materials
Selection of Analytical Wavelength
Optimization of HPTLC Method
Instrumentation
Validation of HPTLC Method
Optimization of Procedures
Linearity
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call